# Franklin Ethereum Trust: financial statements, quarterly

EZET · CBOE · CIK 2011535 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ezet.md) · [Financials](/companies/ezet/financials.md) · [Filings](/companies/ezet/filings.md) · [Insiders](/companies/ezet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ezet/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2026 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [8.5](/filings/0001140361-26-005778.md) | [7.2](/filings/0001140361-26-033204.md) | [26.9](/filings/0001140361-25-041936.md) | [(24.5)](/filings/0001140361-26-005778.md) | [(17.6) d](/filings/0001140361-26-026753.md) | [(10.6)](/filings/0001140361-26-033204.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2026 (2024-06-30) | period not labelled (2024-07-22) | Q3 FY2026 (2024-09-30) | Q3 FY2026 (2024-12-31) | FY2026 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [2.7](/filings/0001193125-24-200706.md) | not reported | [31.0](/filings/0001193125-24-255764.md) | [41.8](/filings/0001140361-25-004062.md) | [21.6](/filings/0001140361-26-026753.md) | [35.1](/filings/0001140361-25-030870.md) | [91.0](/filings/0001140361-25-041936.md) | [59.7](/filings/0001140361-26-005778.md) | [42.2](/filings/0001140361-26-033204.md) | [32.6](/filings/0001140361-26-033204.md) |
| Total liabilities | $m | not reported | not reported | not reported | [0.0](/filings/0001140361-25-004062.md) | [0.0](/filings/0001140361-26-026753.md) | [0.0](/filings/0001140361-25-030870.md) | [0.0](/filings/0001140361-25-041936.md) | [2.3](/filings/0001140361-26-005778.md) | [0.0](/filings/0001140361-26-033204.md) | [0.0](/filings/0001140361-26-033204.md) |
| Shareholders' equity | $m | not reported | [2.6](/filings/0001140361-26-026753.md) | [37.9](/filings/0001140361-26-005778.md) | [40.3](/filings/0001140361-26-005778.md) | [38.8](/filings/0001140361-26-033204.md) | [45.2](/filings/0001140361-26-033204.md) | [74.1](/filings/0001140361-26-005778.md) | [65.2](/filings/0001140361-26-005778.md) | [67.6](/filings/0001140361-26-033204.md) | [68.6](/filings/0001140361-26-033204.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.3)](/filings/0001140361-26-033204.md) | [(28.9) d](/filings/0001140361-25-041936.md) | [6.7 d](/filings/0001140361-26-005778.md) | [(0.1) d](/filings/0001140361-26-026753.md) | [(1.0)](/filings/0001140361-26-033204.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 2,700,000 at 2026-08-03, from the cover of the [10-Q filed 2026-08-14](/filings/0001140361-26-033204.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.